Teract DX Liquid Oral represents an advanced therapeutic formulation specifically designed for comprehensive cough management. This triple-action medication combines expectorant, a...

Teract DX Liquid Oral represents an advanced therapeutic formulation specifically designed for comprehensive cough management. This triple-action medication combines expectorant, antitussive, and mucolytic properties to effectively address dry cough and respiratory congestion. The precise formulation contains Dextromethorphan HBr 15 mg for extended antitussive action lasting 6-8 hours, Phenylephrine HCI 5 mg for nasal decongestion, Chlorpheniramine Maleate 2 mg for allergic manifestations, and Menthol 1 mg per 5 ml to soothe inflamed mucosa. This scientifically developed solution provides reliable relief from persistent coughing while addressing multiple respiratory symptoms simultaneously.

This liquid oral serves critical roles across multiple healthcare sectors, particularly in respiratory medicine and clinical practice. Hospitals and medical clinics utilize Teract DX for treating bronchial asthma, pulmonary emphysema, and chronic obstructive pulmonary disease where comprehensive cough management is essential. Pharmaceutical distributors supply this formulation to retail pharmacies and healthcare providers for managing cough associated with upper respiratory tract infections, seasonal allergies, and smoker's cough. The product meets the needs of medical professionals seeking effective solutions for both allergic and non-allergic respiratory conditions, making it an essential component in pulmonary care protocols and general practice medicine.

The business value of Teract DX lies in its proven reliability, clinical effectiveness, and consistent therapeutic outcomes. Manufacturers ensure superior quality through stringent production standards and rigorous quality control measures, providing partners with products that build patient trust and practitioner confidence. The formulation offers healthcare businesses competitive advantages through its comprehensive action, lasting effects, and ability to address multiple cough symptoms simultaneously, reducing the need for multiple medications. This reliability translates into consistent patient satisfaction and repeat prescriptions, making it a valuable addition to any respiratory care portfolio.

Key Features:
- Triple-action formula combining expectorant, antitussive, and mucolytic properties
- Dextromethorphan HBr providing 6-8 hours of non-narcotic antitussive action
- Phenylephrine HCI for effective nasal decongestion and breathing improvement
- Chlorpheniramine Maleate addressing allergic manifestations and histamine response
- Menthol component for soothing inflamed mucosa and throat irritation relief

Benefits:
- Comprehensive cough relief addressing multiple respiratory symptoms simultaneously
- Extended therapeutic action providing 6-8 hours of consistent cough suppression
- Effective management of both allergic and non-allergic cough presentations
- Soothing relief for throat irritation and inflamed respiratory mucosa
- Proven clinical efficacy in treating asthma, COPD, and respiratory conditions